Analysis of the prognostic impact of DCLK1 in the IBC-NED cases and non-NED luminal cases found that DCLK1 expression was associated with better DFS (log-rank= 12.187, p < 0.001) and OS (log-rank=7.222, p = 0.007) in IBC-NED but not in non-NED luminal cancers (Figure 2). The gene discussed is DCLK1; the disease is cancer.